**6. Current recommendations for revascularisation in diabetics**

Contemporary guidelines place emphasis on the long-term survival benefit conferred by CABG, for treatment of diabetics with multivessel disease. A clinician's judgement on the revascularisation strategy remains an important factor. Although PCI with DES has narrowed the gap with surgery, following the results of the FREEDOM trial in CABG-eligible diabetic patients multivessel disease, CABG remains the gold standard treatment [16, 96] (**Tables 3** and **4**).


*CABG = coronary artery bypass graft; CAD = coronary artery disease; DM = diabetes mellitus; LAD = left anterior descending coronary artery; PCI = percutaneous coronary intervention; SYNTAX = Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery.*

#### **Table 3.**

*Recommendations for the type of revascularization in patients with diabetes with stable coronary artery disease, suitable coronary anatomy for both procedures, and low predicted surgical mortality. Adapted from 2018 ESC/EACTS Guidelines on myocardial revascularization.*


*CABG = coronary artery bypass graft; CCS = chronic coronary syndromes; DES = drug-eluting stent; DM = diabetes mellitus; EACTS = European Association for Cardio-Thoracic Surgery; ESC = European Society of Cardiology; LAD = left anterior descending coronary artery; PCI = percutaneous coronary intervention.*

#### **Table 4.**

*Recommendations for coronary revascularisation in patients with diabetes. Adapted from 2018 ESC/EACTS Guidelines on myocardial revascularization.*
